3.CT findings of thymic tumors.
Ho Son CHUNG ; Sang Jin LEE ; Mi Soo HWANG ; Kil Ho CHO ; Jae Chun CHANG ; Bok Hwan PARK
Journal of the Korean Radiological Society 1991;27(3):343-347
No abstract available.
Thymus Neoplasms*
5.Two Cases of Ectopic Cervical Thymic Tumors Mimicking as Thyroid Tumors.
Yoon Woo KOH ; Jae Hong PARK ; Jang Yul BYUN ; Hee Kyung KIM
Korean Journal of Otolaryngology - Head and Neck Surgery 2005;48(12):1536-1540
The thymus arises from the ventral wings of the third and fourth branchial pouches in the embryo. Subsequently, the thymus passes down to the mediastinum by the sixth week of gestation. Several unusual conditions such as remnants of the thymus and incomplete descent may occur along the path of descent. Therefore, thymic diseases such as thymoma, thymic hyperplasia, and thymic cyst can be found in the neck. Thymoma is the most common anterior mediastinal mass in adult. Rarely, it is presented as an anterior neck mass, commonly located in the anterolateral aspect of the neck or adjacent to the thyroid. Cervical thymic cyst is uncommon and usually occurs in the first and second decades. Cervical thymic cyst after the third decade is so rare that it is very difficult to diagnose preoperatively. We experienced two cases of cervical thymic neoplasm in the lower anterior neck in an adult. Here, we present the cases with a review of the related literatures.
Adult
;
Embryonic Structures
;
Humans
;
Mediastinal Cyst
;
Mediastinum
;
Neck
;
Pregnancy
;
Thymoma
;
Thymus Gland
;
Thymus Hyperplasia
;
Thymus Neoplasms*
;
Thyroid Gland*
6.Expression of bcl-2 , p53 Protein and Aggressiveness in Thymic Epithelial Tumor.
The Korean Journal of Thoracic and Cardiovascular Surgery 1999;32(8):726-731
BACKGROUND: The distinction between non-invasive and invasive or thymic carcinoma has been severely compromised by lack of objective morphological criteria. A reliable biological marker of tumor aggressiveness is, therefore, mandatory for predicting tumor behavior. MATERIAL AND METHOD: Thirty thymic epithelial tumors, including 7 non-invasive thymoma, 10 invasive thymoma, and 13 thymic carcinoma of the Rosai's classification; and 5 stage I, 7 stage II, 2 stage III, and 3 stage IVa of the Masaoka stage of thymoma were investigated for expression of bcl-2 and p53 proteins by immunohistochemistry. RESULT: The thymic epithelial cells showed positive immunostain for bcl-2 in 0 (0%), 3 (30%), 8 (61.5%) of categories in the Rosai's classification respectively and in 0 (0%), 1 (14.3%), 2 (100%), 0 (0%) of stage I, II, III, IVa of the Masaoka stage respectively. Thymic carcinoma, and high stage thymoma had significantly higher proportion of bcl-2 expression than thymoma (p=0.021) and low stage thymoma (p=0.011). However, p53 showed no correlation with the histological subtypes nor with clinical aggressiveness. Bcl-2 expression appeared to be positively correlated with p53 immunoactivity (p=0.007, kappa=0.525). CONCLUSION: These date indicate that bcl-2 expression correlates with aggressiveness in thymic epithelial tumors, but further studies on mutation of p53 protein is necessary because bcl-2 expression appeared to be positively correlated with p53 immunoactivity.
Biomarkers
;
Classification
;
Epithelial Cells
;
Immunohistochemistry
;
Thymoma
;
Thymus Neoplasms
7.Thymic Carcinoid Tumor: 1 Case report.
Jae Young LEE ; Myung Chun KIM ; Seh Young YOU ; Hwang Rae JO ; Hong Mo KANG ; Moon Ho YANG
The Korean Journal of Thoracic and Cardiovascular Surgery 1998;31(3):319-323
Thymic carcinoid tumor is a rare mediastinal tumor, which was firstly described by Rosai and Higa in 1972. A carcinoid tumor of the thymus has recently been regarded as a distinct tumor from thymoma, and is probably Kultschizky cell origin. The pathologic diagnosis of thymic carcinoid is made from findings from light microscopy, immunohistochemical studies and electron microscopy. About 50% of thymic carcinoids were seen with endocrinopathies. Recurrences and extrathoracic metastasis are characteristics of thymic carcinoids. Surgical removal of the intial and tumor recurred are considered to be the most effective treatment today. However, the role of the adjuvant radiotherapy and the chemotherapy is still uncertain. Herein we report a case of thymic carcinoid tumor, which was confirmed by operation and pathologic study.
Carcinoid Tumor*
;
Diagnosis
;
Drug Therapy
;
Mediastinal Neoplasms
;
Microscopy
;
Microscopy, Electron
;
Neoplasm Metastasis
;
Radiotherapy, Adjuvant
;
Recurrence
;
Thymoma
;
Thymus Gland
;
Thymus Neoplasms
8.Ectopic Adrenocorticotropic Hormone Syndrome Associated With Thymic Carcinoma in Old Age.
Min Gyu KIM ; Il Hwan RYU ; Joo Seok KIM ; Su A YOON ; Jae Min LEE ; Hye Min YU ; Kang Seo PARK
Journal of the Korean Geriatrics Society 2013;17(4):228-233
A 70-year-old woman who developed a moon face was hospitalized. At admission, adrenocorticotropic hormone (ACTH) and serum cortisol levels were elevated. A high-dose dexamethasone suppression test demonstrated that cortisol secretion was uninhibited. Furthermore, chest computed tomography revealed an anterior mediastinal mass. On the basis of these results, ectopic ACTH syndrome was diagnosed and complete resection of the thymic tumor was performed. Histological examination revealed large cell neuroendocrine carcinoma of the thymus and positive immunoreactivity for ACTH. However, despite complete excision of the thymic tumor, ACTH and serum cortisol levels were high. Therefore, we investigated whether the lesion had recurred or metastasized; however, the results were inconclusive. Finally, laparoscopic bilateral adrenalectomy was performed to control the hypercortisolemia. After the surgery, the serum cortisol level was well-controlled and the general condition of the patient was good.
ACTH Syndrome, Ectopic
;
Adrenalectomy
;
Adrenocorticotropic Hormone*
;
Aged
;
Carcinoma, Neuroendocrine
;
Dexamethasone
;
Female
;
Humans
;
Hydrocortisone
;
Thorax
;
Thymoma*
;
Thymus Gland
;
Thymus Neoplasms
9.Pathological Findings of Tumors at Thymus and Myasthenia Gravis.
Soo Jin CHO ; Il Nam SUNWOO ; Ki Whan KIM ; Dong Whan SHIN
Journal of the Korean Neurological Association 1996;14(1):190-196
We retrospectively studied 53 cases of thymic tumors diagnosed after thymectomy to clearfied the pathologic difference of thymic tumor associated with myasthenia gravis and without myasthenia gravis. Among them, there are 23 cases with myasthenia gravis; 19 among 36 thymomas(52.8%), 3 of 4 thymolipoma (75%) and 1 squamous cell carcinoma. Lymphoma and teratoma are not associated with myasthenia gravis. There is no significant difference in the prevalence of myasthenia gravis between types of the old traditional classification of thymoma. But according to the new Muller-Hermelink classification, about two-thirds of myasthenia gravis have the thymoma with cortical cell origin. The prevalence of myasthenia gavis were relatively low in the patients with thymoma of medullary or mixed type. The frequent association of myasthenia gravis was suggesting that the thymolipoma might be a variant of thymoma, cortical type.
Carcinoma, Squamous Cell
;
Classification
;
Humans
;
Lymphoma
;
Myasthenia Gravis*
;
Prevalence
;
Retrospective Studies
;
Teratoma
;
Thymectomy
;
Thymoma
;
Thymus Gland*
;
Thymus Neoplasms